WASHINGTON — President Trump’s forthcoming proposal to lower the cost of expensive physician-administered drugs will hit three drug companies — Amgen, Genentech, and Regeneron — harder than anyone else.

Trump is expected to roll out a pilot program Thursday that would tie reimbursement for certain expensive drugs to the prices paid in other similar countries, POLITICO reports. And the Department of Health and Human Services is already out with a report that names the specific drug companies that charge more for their medicines in the U.S. than in other countries.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Populism in drug pricing is great as a ploy to keep power, because people depend on the drugs we have already developed. But, if you don’t want Jim Cancer to run free, then make sure to keep the bounty high. That’s the only way we will be sure to get the best and brightest to burn the midnight oil to figure out the answers, and to get Daddy Warbucks to fork over a king’s ransom to finance research with way less than a heads-or-tails chance of success to find the holy grail for something you may one day be diagnosed with.
    Populism is the cancer. It destroys everything over a long enough time horizon. It really is that simple.

  • The majority of Americans want Medicare for All, which will be the only way to bring down these drug prices. Unfortunately we have already seen what Industry Insiders have done to drug prices. This is merely another stunt, meant to deceive the public.

  • If that happens then he cannot claim anymore that the rest of the world is raping and sponging of the US. SAD!

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy